摘要:
A method for potentiating the antitumor immunity in an animal by administering REIC/Dkk-3, or a therapeutic agent for malignant mesothelioma containing REIC/Dkk-3, or a vector containing the DNA as an active ingredient; wherein the DNA consists of the nucleotide sequence shown in SEQ ID NO: 1; or (b) a DNA hybridizing under stringent conditions to the DNA consisting of a nucleotide sequence complementary to the nucleotide sequence shown in SEQ ID NO: 1 and encoding a protein having apoptosis-inducing activity and interleukin (IL-7) production-accelerating activity in cells.
摘要翻译:通过施用REIC / Dkk-3或含有REIC / Dkk-3的恶性间皮瘤的治疗剂或含有该DNA作为活性成分的载体来增强动物的抗肿瘤免疫力的方法。 其中DNA由SEQ ID NO:1所示的核苷酸序列组成; 或(b)在严格条件下与由与SEQ ID NO:1所示核苷酸序列互补的核苷酸序列组成的DNA杂交并编码具有凋亡诱导活性和白细胞介素(IL-7)产生加速活性的蛋白质的DNA 在细胞中。
摘要:
According to the present invention, an apoptosis-inducing agent for prostate cancer comprising REIC/Dkk-3 DNA or an REIC/Dkk-3 protein, and a therapeutic agent for prostate cancer and an agent for inhibiting prostate cancer metastasis that comprise such apoptosis-inducing agent are provided.An apoptosis-inducing agent for prostate cancer, comprising, as an active ingredient, an REIC/Dkk-3 protein (a) or (b) or REIC/Dkk-3 DNA (c) or (d): (a) a protein consisting of the amino acid sequence represented by SEQ ID NO: 2; (b) a protein consisting of an amino acid sequence derived from the amino acid sequence represented by SEQ ID NO: 2 by substitution or deletion of 1 or more amino acids; (c) DNA consisting of the nucleotide sequence represented by SEQ ID NO: 1; or (d) DNA that hybridizes under stringent conditions to DNA consisting of a nucleotide sequence complementary to the nucleotide sequence represented by SEQ ID NO: 1 and encodes a protein having apoptosis activity; and a therapeutic agent for prostate cancer comprising such apoptosis-inducing agent are provided
摘要翻译:根据本发明,包含REIC / Dkk-3 DNA或REIC / Dkk-3蛋白的前列腺癌细胞凋亡诱导剂,前列腺癌治疗剂和抑制前列腺癌转移的药剂, 提供诱导剂。 一种用于前列腺癌的凋亡诱导剂,其包含REIC / Dkk-3蛋白(a)或(b)或REIC / Dkk-3 DNA(c)或(d)作为活性成分:(a)蛋白质 由SEQ ID NO:2表示的氨基酸序列组成; (b)通过取代或缺失1个或多个氨基酸由SEQ ID NO:2所示的氨基酸序列衍生的氨基酸序列组成的蛋白质; (c)由SEQ ID NO:1表示的核苷酸序列组成的DNA; 或(d)在严格条件下与由与SEQ ID NO:1所示的核苷酸序列互补的核苷酸序列组成的DNA杂交的DNA,并编码具有凋亡活性的蛋白质; 并提供包含这种凋亡诱导剂的前列腺癌治疗剂
摘要:
This invention provides an inducer of apoptosis in cancer cells comprising a fragment of the REIC/Dkk-3 gene and a cancer therapeutic agent comprising the same. This invention also provides a polynucleotide fragment encoding the REIC/Dkk-3 protein (a) or (b), which encodes a polypeptide having apoptosis activity: (a) a polynucleotide encoding a polypeptide comprising an amino acid sequence of amino acid 1 to any of amino acids 39 to 78 of the amino acid sequence of the REIC/Dkk-3 protein as shown in SEQ ID NO: 2; or (b) a polynucleotide encoding a polypeptide comprising an amino acid sequence derived from the amino acid sequence of amino acid 1 to any of amino acids 39 to 78 of the amino acid sequence of the REIC/Dkk-3 protein as shown in SEQ ID NO: 2 by substitution, deletion, or addition of 1 or several amino acids and having apoptosis activity.
摘要翻译:本发明提供了包含REIC / Dkk-3基因的片段的癌细胞中的凋亡诱导剂和包含其的癌症治疗剂。 本发明还提供编码具有凋亡活性的多肽的编码REIC / Dkk-3蛋白(a)或(b)的多核苷酸片段:(a)编码包含氨基酸1的氨基酸序列的多肽的多核苷酸至任何 的如SEQ ID NO:2所示的REIC / Dkk-3蛋白的氨基酸序列的氨基酸39至78; 或(b)编码多肽的多核苷酸,其包含衍生自SEQ ID NO:1所示的REIC / Dkk-3蛋白的氨基酸序列的氨基酸1至氨基酸39至78的氨基酸序列的氨基酸序列的氨基酸序列 NO:2通过取代,缺失或添加1个或几个氨基酸并具有凋亡活性。
摘要:
According to the present invention, a method for treating malignant mesothelioma using REIC/Dkk-3 and a therapeutic agent for malignant mesothelioma comprising REIC/Dkk-3 are provided. A mesothelioma therapeutic agent is provided, comprising the following REIC/Dkk-3 DNA or a vector comprising the DNA as an active ingredient: (a) a DNA consisting of the nucleotide sequence shown in SEQ ID NO: 1; or (b) a DNA hybridizing under stringent conditions to a DNA consisting of a nucleotide sequence complementary to the nucleotide sequence shown in SEQ ID NO: 1 and encoding a protein having apoptosis-inducing activity and IL-7 production-accelerating activity in cells.
摘要翻译:根据本发明,提供了使用REIC / Dkk-3治疗恶性间皮瘤的方法和包含REIC / Dkk-3的恶性间皮瘤治疗剂。 提供间皮瘤治疗剂,其包含以下REIC / Dkk-3 DNA或包含该DNA作为活性成分的载体:(a)由SEQ ID NO:1所示核苷酸序列组成的DNA; 或(b)在严格条件下与由与SEQ ID NO:1所示核苷酸序列互补的核苷酸序列组成的DNA杂交并编码细胞中具有凋亡诱导活性和IL-7生产加速活性的蛋白质的DNA。
摘要:
This invention provides an inducer of apoptosis in cancer cells comprising a fragment of the REIC/Dkk-3 gene and a cancer therapeutic agent comprising the same. This invention also provides a polynucleotide fragment encoding the REIC/Dkk-3 protein (a) or (b), which encodes a polypeptide having apoptosis activity: (a) a polynucleotide encoding a polypeptide comprising an amino acid sequence of amino acid 1 to any of amino acids 39 to 78 of the amino acid sequence of the REIC/Dkk-3 protein as shown in SEQ ID NO: 2; or (b) a polynucleotide encoding a polypeptide comprising an amino acid sequence derived from the amino acid sequence of amino acid 1 to any of amino acids 39 to 78 of the amino acid sequence of the REIC/Dkk-3 protein as shown in SEQ ID NO: 2 by substitution, deletion, or addition of 1 or several amino acids and having apoptosis activity.
摘要翻译:本发明提供了包含REIC / Dkk-3基因的片段的癌细胞中的凋亡诱导剂和包含其的癌症治疗剂。 本发明还提供编码具有凋亡活性的多肽的编码REIC / Dkk-3蛋白(a)或(b)的多核苷酸片段:(a)编码包含氨基酸1的氨基酸序列的多肽的多核苷酸至任何 的如SEQ ID NO:2所示的REIC / Dkk-3蛋白的氨基酸序列的氨基酸39至78; 或(b)编码多肽的多核苷酸,其包含衍生自SEQ ID NO:1所示的REIC / Dkk-3蛋白的氨基酸序列的氨基酸1至氨基酸39至78的氨基酸序列的氨基酸序列的氨基酸序列 NO:2通过取代,缺失或添加1个或几个氨基酸并具有凋亡活性。
摘要:
According to the present invention, an apoptosis-inducing agent for prostate cancer comprising REIC/Dkk-3 DNA or an REIC/Dkk-3 protein, and a therapeutic agent for prostate cancer and an agent for inhibiting prostate cancer metastasis that comprise such apoptosis-inducing agent are provided.An apoptosis-inducing agent for prostate cancer, comprising, as an active ingredient, an REIC/Dkk-3 protein (a) or (b) or REIC/Dkk-3 DNA (c) or (d): (a) a protein consisting of the amino acid sequence represented by SEQ ID NO: 2; (b) a protein consisting of an amino acid sequence derived from the amino acid sequence represented by SEQ ID NO: 2 by substitution or deletion of 1 or more amino acids; (c) DNA consisting of the nucleotide sequence represented by SEQ ID NO: 1; or (d) DNA that hybridizes under stringent conditions to DNA consisting of a nucleotide sequence complementary to the nucleotide sequence represented by SEQ ID NO: 1 and encodes a protein having apoptosis activity; and a therapeutic agent for prostate cancer comprising such apoptosis-inducing agent are provided
摘要翻译:根据本发明,包含REIC / Dkk-3 DNA或REIC / Dkk-3蛋白的前列腺癌细胞凋亡诱导剂,前列腺癌治疗剂和抑制前列腺癌转移的药剂, 提供诱导剂。 一种用于前列腺癌的凋亡诱导剂,其包含REIC / Dkk-3蛋白(a)或(b)或REIC / Dkk-3 DNA(c)或(d)作为活性成分:(a)蛋白质 由SEQ ID NO:2表示的氨基酸序列组成; (b)通过取代或缺失1个或多个氨基酸由SEQ ID NO:2所示的氨基酸序列衍生的氨基酸序列组成的蛋白质; (c)由SEQ ID NO:1表示的核苷酸序列组成的DNA; 或(d)在严格条件下与由与SEQ ID NO:1所示的核苷酸序列互补的核苷酸序列组成的DNA杂交的DNA,并编码具有凋亡活性的蛋白质; 并提供包含这种凋亡诱导剂的前列腺癌治疗剂
摘要:
This invention provides an inducer of apoptosis in cancer cells comprising a fragment of the REIC/Dkk-3 gene and a cancer therapeutic agent comprising the same. This invention also provides a polynucleotide fragment encoding the REIC/Dkk-3 protein (a) or (b), which encodes a polypeptide having apoptosis activity: (a) a polynucleotide encoding a polypeptide comprising an amino acid sequence of amino acid 1 to any of amino acids 39 to 78 of the amino acid sequence of the REIC/Dkk-3 protein as shown in SEQ ID NO: 2; or (b) a polynucleotide encoding a polypeptide comprising an amino acid sequence derived from the amino acid sequence of amino acid 1 to any of amino acids 39 to 78 of the amino acid sequence of the REIC/Dkk-3 protein as shown in SEQ ID NO: 2 by substitution, deletion, or addition of 1 or several amino acids and having apoptosis activity.
摘要翻译:本发明提供了包含REIC / Dkk-3基因的片段的癌细胞中的凋亡诱导剂和包含其的癌症治疗剂。 本发明还提供编码具有凋亡活性的多肽的编码REIC / Dkk-3蛋白(a)或(b)的多核苷酸片段:(a)编码包含氨基酸1的氨基酸序列的多肽的多核苷酸至任何 的如SEQ ID NO:2所示的REIC / Dkk-3蛋白的氨基酸序列的氨基酸39至78; 或(b)编码多肽的多核苷酸,其包含衍生自SEQ ID NO:1所示的REIC / Dkk-3蛋白的氨基酸序列的氨基酸1至氨基酸39至78的氨基酸序列的氨基酸序列的氨基酸序列 NO:2通过取代,缺失或添加1个或几个氨基酸并具有凋亡活性。
摘要:
According to the present invention, a composition for inducing or activating dendritic cell-like cells so as to treat or prevent cancer by immunotherapy is provided.Specifically, the following is provided: an agent for activating cancer immunity, which comprises, as an active ingredient, the following REIC protein: (a) a protein consisting of the amino acid sequence shown in SEQ ID NO: 2; or (b) a protein consisting of an amino acid sequence derived from the amino acid sequence shown in SEQ ID NO: 2 by substitution, deletion, or addition of one or more amino acid(s) and having the activity of inducing differentiation from monocytes into dendritic cell-like cells.
摘要翻译:根据本发明,提供了用于诱导或激活树突状细胞样细胞以通过免疫治疗来治疗或预防癌症的组合物。 具体而言,提供以下功能:用于激活癌症免疫的药剂,其包含作为活性成分的以下REIC蛋白质:(a)由SEQ ID NO:2所示的氨基酸序列组成的蛋白质; 或(b)通过取代,缺失或添加一个或多个氨基酸并且具有诱导从单核细胞分化的活性的由源自SEQ ID NO:2所示氨基酸序列的氨基酸序列组成的蛋白质 进入树突状细胞样细胞。
摘要:
According to the present invention, a composition for inducing or activating dendritic cell-like cells so as to treat or prevent cancer by immunotherapy is provided.Specifically, the following is provided: an agent for activating cancer immunity, which comprises, as an active ingredient, the following REIC protein: (a) a protein consisting of the amino acid sequence shown in SEQ ID NO: 2; or (b) a protein consisting of an amino acid sequence derived from the amino acid sequence shown in SEQ ID NO: 2 by substitution, deletion, or addition of one or more amino acid(s) and having the activity of inducing differentiation from monocytes into dendritic cell-like cells.
摘要翻译:根据本发明,提供了用于诱导或激活树突状细胞样细胞以通过免疫治疗来治疗或预防癌症的组合物。 具体而言,提供以下功能:用于激活癌症免疫的药剂,其包含作为活性成分的以下REIC蛋白质:(a)由SEQ ID NO:2所示的氨基酸序列组成的蛋白质; 或(b)通过取代,缺失或添加一个或多个氨基酸并且具有诱导从单核细胞分化的活性的由源自SEQ ID NO:2所示氨基酸序列的氨基酸序列组成的蛋白质 进入树突状细胞样细胞。
摘要:
This invention provides an inducer of apoptosis in cancer cells comprising a fragment of the REIC/Dkk-3 gene and a cancer therapeutic agent comprising the same. This invention also provides a polynucleotide fragment encoding the REIC/Dkk-3 protein (a) or (b), which encodes a polypeptide having apoptosis activity: (a) a polynucleotide encoding a polypeptide comprising an amino acid sequence of amino acid 1 to any of amino acids 39 to 78 of the amino acid sequence of the REIC/Dkk-3 protein as shown in SEQ ID NO: 2; or (b) a polynucleotide encoding a polypeptide comprising an amino acid sequence derived from the amino acid sequence of amino acid 1 to any of amino acids 39 to 78 of the amino acid sequence of the REIC/Dkk-3 protein as shown in SEQ ID NO: 2 by substitution, deletion, or addition of 1 or several amino acids and having apoptosis activity.
摘要翻译:本发明提供了包含REIC / Dkk-3基因的片段的癌细胞中的凋亡诱导剂和包含其的癌症治疗剂。 本发明还提供编码具有凋亡活性的多肽的编码REIC / Dkk-3蛋白(a)或(b)的多核苷酸片段:(a)编码包含氨基酸1的氨基酸序列的多肽的多核苷酸至任何 的如SEQ ID NO:2所示的REIC / Dkk-3蛋白的氨基酸序列的氨基酸39至78; 或(b)编码多肽的多核苷酸,其包含衍生自SEQ ID NO:1所示的REIC / Dkk-3蛋白的氨基酸序列的氨基酸1至氨基酸39至78的氨基酸序列的氨基酸序列的氨基酸序列 NO:2通过取代,缺失或添加1个或几个氨基酸并具有凋亡活性。